Skip to main content
SpringerLink
Log in

Glucokinase-Maturity-Onset Diabetes of the Young en zwangerschap

  • Casuïstiek
  • Published:
Nederlands Tijdschrift voor Diabetologie Aims and scope

Samenvatting

Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY), voorheen MODY-2 genoemd, is een monogenetische, dominant overervende aandoening. De aandoening kenmerkt zich door licht verhoogde glucosespiegels en behoeft geen behandeling buiten de zwangerschap.1,2 Tijdens de zwangerschap is soms behandeling nodig. In deze klinische les gaan we in op de behandelindicatie van GCK-MODY in de zwangerschap. Voor iedereen die te maken heeft met zwangerschapsdiabetes is het van belang vrouwen met GCK-MODY te onderscheiden van vrouwen met zwangerschapsdiabetes. Ook hierop zullen we in deze klinische les ingaan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figuur 1.

Referenties

  1. Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia. JAMA. 2014;311:27–9.

    Article  Google Scholar 

  2. Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetolo­gia. 2013;57:54–6.

    Article  Google Scholar 

  3. Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:91–5.

    Article  Google Scholar 

  4. Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. American Journal of Obstetrics and Gynecology. 2001;185:240–1.

    Article  CAS  PubMed  Google Scholar 

  5. Chakera AJ, Carleton VL, Ellard S, Wong J, Yue DK, Pinner J, et al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia Due to a Glucokinase Mutation Requires Treatment. Diabetes Care. 2012;35:1832–4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Njølstad PR, Søvik O, Cuesta-Muñoz A, Bjørkhaug L, Massa O, Barbetti F, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344:1588–92.

    Article  PubMed  Google Scholar 

  7. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19:268–70.

    Article  CAS  PubMed  Google Scholar 

  8. Spyer G, Macleod KM, Shepherd M, Ellard S, Hattersley AT. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabetic Medicine. 2009;26:14–8.

    Article  CAS  PubMed  Google Scholar 

  9. Misra S, Dornhorst A. Gestational Diabetes Mellitus: Primum Non Nocere. Diabetes Care. 2012;35:1811–3.

    Article  PubMed  PubMed Central  Google Scholar 

  10. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in preg­nancy. Diabetes Care. 2010. pp. 676–82.

  11. Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TRJ, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012;35:574–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chakera AJ, Spyer G, Vincent N, Ellard S, Hattersley AT, Dunne FP. The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort. Diabetes Care. 2014;37:1230–6.

    Article  CAS  PubMed  Google Scholar 

  13. Iafusco D, Napoli A, Balbi G, Tinto N, Sacchetti L, Giuliani C, et al. Breaking down misclassifications: not all gestational diabetes needs treatment as not all children need insulin. Diabetologia. 2013. 566 p.

  14. Rudland VL, Hinchcliffe M, Pinner J, Cole S, Mercorella B, Molyneaux L, et al. Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA1c: Table 1. Diabetes Care. 2015 22;39:50–2.

  15. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature. 2001;414:788–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Isala Diabetescentrum, 10400, 8000, GK, Zwolle, The Netherlands

    T.M. Vriesendorp, H. Kip & A.M. Sebel

  2. Afdeling klinische genetica, Universitair Medisch Centrum Groningen, Groningen, The Netherlands

    P. Rump

  3. Isala Vrouw en Kindcentrum, Zwolle, The Netherlands

    S.W. Nij Bijvanck & W.K. Kuchenbecker

Authors
  1. T.M. Vriesendorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Kip
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A.M. Sebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Rump
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S.W. Nij Bijvanck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W.K. Kuchenbecker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T.M. Vriesendorp.

Additional information

1 Isala Diabetescentrum, Zwolle

2 Afdeling klinische genetica, Universitair Medisch Centrum Groningen

3 Isala Vrouw en Kindcentrum, Zwolle

Correspondentie: Titia Vriesendorp Diabetescentrum Isala Postbus 10400 8000 GK Zwolle t.vriesendorp@isala.nl

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vriesendorp, T., Kip, H., Sebel, A. et al. Glucokinase-Maturity-Onset Diabetes of the Young en zwangerschap. Ned Tijdschr Diabetol 15, 17–20 (2017). https://doi.org/10.1007/s12467-017-0004-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12467-017-0004-5

Search

Navigation